3Scan Closes Series A Funding Round at over $6 million

SF Startup Law client 3Scan publicly announced that it closed its Series A funding round at $6.67 million backed by Lux Capital and Dolby Ventures.

3Scan has innovated the technology behind the Knife Edge Scanning Microscope, or KESM, which slices and images a section of tissue and translates this data into a 3D model on a micro-cellular level. This novel technology has numerous applications for medical diagnostics and disease pathology, allowing researcers and scientists to travel through the smallest structures of the body.

3Scan has been building their company's valuation by filing patents to protect this innovative technology, employing the services of SF Startup Law.

To read more see the press release on Business Wire or visit www.3scan.com